Identifying Therapeutic Targets for Triple-Negative Breast Cancer using a Novel Mathematical Model of the Tumor Microenvironment

TL;DR

This paper introduces a new mathematical model of the tumor microenvironment in triple-negative breast cancer, identifying key cellular interactions and potential therapeutic targets to inform future treatment strategies.

Contribution

The study develops a novel ODE-based model of TNBC TME, integrating literature and expert input to analyze cellular interactions and identify influential pathways for therapy.

Findings

Key pathways influencing tumor burden identified

Model highlights stromal-mediated tumor support mechanisms

Framework supports hypothesis generation for combination therapies

Abstract

Triple-negative breast cancer (TNBC) is an aggressive disease with high mortality and limited treatment options, due to its lack of receptors that have targeted therapies available. The tumor microenvironment (TME) plays a critical role in TNBC progression and therapeutic resistance. In this work, we developed a novel mathematical model to describe key cellular interactions within the TNBC TME, informed by current literature and expert input. Our model consists of a system of ordinary differential equations representing five interacting cell populations: M2 macrophages, cancer-associated fibroblasts, TNBC tumor cells, cytotoxic T lymphocytes, and regulatory T cells. We performed global sensitivity analysis to determine which model parameters most strongly influence tumor burden over a clinically-relevant treatment timeframe. The pathways associated with the most-influential parameters correspond to biological mechanisms that are consistent with known and emerging therapeutic strategies in TNBC, including stromal-mediated tumor support. These results highlight key regulatory interactions within the TNBC TME and provide a quantitative framework for hypothesis generation and future investigation of combination treatment strategies.